[2 min read] New cryotherapy guidelines | Prof David Wilkinson

cryotherapy

The new Non-Melanoma Skin Cancer Guidelines have been released. A PDF summary of the key recommendations is helpfully provided, which is well worth a read and important to become familiar with. Continue reading “[2 min read] New cryotherapy guidelines | Prof David Wilkinson”

[4 min read] Blocking key regulator could treat non-melanoma skin cancers

The outer layer of the skin completely replaces itself every two to four weeks, but when this process is blocked, cancer can grow. A new study from researchers at the University of Pennsylvania has now identified a key regulator of that block known as LSD1, as well as a way to genetically influence the skin to grow in a way that prevents this block from happening. Continue reading “[4 min read] Blocking key regulator could treat non-melanoma skin cancers”

[4 min read] Personalised nanovaccines for melanoma

A study has found that personalised nanovaccines are safe, well tolerated, and have an effect in melanoma.
Porous silicon and adenovirus-based bio-hybrid nanovaccines were developed in a study carried out at the University of Helsinki, providing new insights on the structure and efficacy of these systems as therapeutic cancer nanovaccines.

Continue reading “[4 min read] Personalised nanovaccines for melanoma”

[WEBINAR] Benefits and review of Picato for solar keratosis

Picato

In this webinar, Dr Tony Dicker reviews Picato® and its benefits for the treatment of solar keratosis. Dr Dicker discusses the use of lesion-directed therapies in a clinical setting, including the efficacy and skin reactions of Picato®. Continue reading “[WEBINAR] Benefits and review of Picato for solar keratosis”

[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2019]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano discusses how a new therapeutic agent, cemiplimab, might be used in combination with radiotherapy to treat advanced squamous cell carcinoma. Continue reading “[3 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [August 2019]”

[4 min read] Breast cancer drug may treat mucosal melanoma

mucosal melanoma

A drug typically used to treat breast cancer may also be effective in treating mucosal melanoma.

Mucosal melanoma is not linked to UV exposure and is extremely difficult to treat. It occurs on moist tissues inside the body, including the eyes, inside the mouth and nose, gastrointestinal areas and the genital tract.

Continue reading “[4 min read] Breast cancer drug may treat mucosal melanoma”

[2 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2019]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano talks about an interesting patient case that demonstrates the importance of performing an examination of the entire skin surface – even if the patient is only concerned about one particular lesion – and highlights how dermoscopy can both enhance and change our understandings of lesions in the clinical setting. Continue reading “[2 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [July 2019]”

[4 min read] Compounds found that starve melanoma cells of energy

melanoma

Researchers have identified compounds that starve melanoma cells of energy. Scientists at Oregon State University and Oregon Health & Science University have found a possible way of beating the drug resistance of melanoma, one of the deadliest forms of skin cancer. Continue reading “[4 min read] Compounds found that starve melanoma cells of energy”

[5 min read] First-line treatment decisions for BRAF-mutated melanoma

melanoma treatment
How do you determine first-line treatment for your patients with melanoma? Treatment decisions for advanced melanoma are increasingly complex and guidelines provide limited advice on how to choose between immunotherapy and targeted therapy for first-line treatment. A Delphi study was carried out to understand which patient characteristics and disease-related factors inform clinicians’ choices of first-line treatment for BRAF-mutated melanoma.

Continue reading “[5 min read] First-line treatment decisions for BRAF-mutated melanoma”

[4 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [June 2019]

skin cancer update

In this month’s skin cancer update video, Professor Giuseppe Argenziano continues his two-part discussion from last month about the role of Imiquimod in the treatment of lentigo maligna. Using real patient case examples, Giuseppe discusses Imiquimod in an adjuvant setting, including how it can be applied in a clinical setting after surgery has been performed. Continue reading “[4 min watch] Skin Cancer Update with Prof Giuseppe Argenziano [June 2019]”